UMP (00722) released its annual performance, with a net profit attributable to shareholders of HK$31.44 million, a year-on-year decrease of 22.6%.

UMP (00722) announced its annual performance for the year ending June 30, 2025, with revenue of HK$727 million, a decrease of 2.9% year-on-year. The company's attributable profit was HK$31.44 million, a decrease of 22.6% year-on-year. Basic earnings per share were HK$0.398, with a proposed final dividend of HK$0.19 per share. The decrease in total revenue during the period was mainly due to a significant decrease in the volume of immigration medical examinations and a reduction in revenue from clinical medical services, despite an increase in revenue from the company's enterprise healthcare solutions business.